153 related articles for article (PubMed ID: 28495606)
1. The synthetic cannabinoid WIN-55,212 induced-apoptosis in cytotrophoblasts cells by a mechanism dependent on CB1 receptor.
Almada M; Costa L; Fonseca BM; Amaral C; Teixeira N; Correia-da-Silva G
Toxicology; 2017 Jun; 385():67-73. PubMed ID: 28495606
[TBL] [Abstract][Full Text] [Related]
2. Synthetic cannabinoids JWH-018, JWH-122, UR-144 and the phytocannabinoid THC activate apoptosis in placental cells.
Almada M; Alves P; Fonseca BM; Carvalho F; Queirós CR; Gaspar H; Amaral C; Teixeira NA; Correia-da-Silva G
Toxicol Lett; 2020 Feb; 319():129-137. PubMed ID: 31730886
[TBL] [Abstract][Full Text] [Related]
3. The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: involvement of both mitochondrial and death receptor pathways.
Costa MA; Fonseca BM; Teixeira NA; Correia-da-Silva G
Placenta; 2015 Jan; 36(1):69-76. PubMed ID: 25465706
[TBL] [Abstract][Full Text] [Related]
4. Synthetic cannabinoids and endometrial stromal cell fate: Dissimilar effects of JWH-122, UR-144 and WIN55,212-2.
Fonseca BM; Fernandes R; Almada M; Santos M; Carvalho F; Teixeira NA; Correia-da-Silva G
Toxicology; 2019 Feb; 413():40-47. PubMed ID: 30502353
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
6. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
[TBL] [Abstract][Full Text] [Related]
7. The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft.
Scuderi MR; Cantarella G; Scollo M; Lempereur L; Palumbo M; Saccani-Jotti G; Bernardini R
Cancer Lett; 2011 Nov; 310(2):240-9. PubMed ID: 21807457
[TBL] [Abstract][Full Text] [Related]
8. 2-arachidonoylglycerol effects in cytotrophoblasts: metabolic enzymes expression and apoptosis in BeWo cells.
Costa MA; Fonseca BM; Keating E; Teixeira NA; Correia-da-Silva G
Reproduction; 2014 Mar; 147(3):301-11. PubMed ID: 24324206
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids Induce Cell Death and Promote P2X7 Receptor Signaling in Retinal Glial Progenitors in Culture.
Freitas HR; Isaac AR; Silva TM; Diniz GOF; Dos Santos Dabdab Y; Bockmann EC; Guimarães MZP; da Costa Calaza K; de Mello FG; Ventura ALM; de Melo Reis RA; França GR
Mol Neurobiol; 2019 Sep; 56(9):6472-6486. PubMed ID: 30838518
[TBL] [Abstract][Full Text] [Related]
10. The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis.
Pellerito O; Calvaruso G; Portanova P; De Blasio A; Santulli A; Vento R; Tesoriere G; Giuliano M
Mol Pharmacol; 2010 May; 77(5):854-63. PubMed ID: 20159939
[TBL] [Abstract][Full Text] [Related]
11. Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis.
Notaro A; Sabella S; Pellerito O; Di Fiore R; De Blasio A; Vento R; Calvaruso G; Giuliano M
Int J Biol Sci; 2014; 10(5):466-78. PubMed ID: 24795528
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.
Roberto D; Klotz LH; Venkateswaran V
Prostate; 2019 Feb; 79(2):151-159. PubMed ID: 30242861
[TBL] [Abstract][Full Text] [Related]
13. [The synthetic cannabinoid analog WIN 55,212-2 potentiates the amplitudes of glycine-activated currents].
Iatsenko NM; Tsintsadze TSh; Lozova NO
Fiziol Zh (1994); 2007; 53(3):31-7. PubMed ID: 17725041
[TBL] [Abstract][Full Text] [Related]
14. PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells.
Hong Y; Zhou Y; Wang Y; Xiao S; Liao DJ; Zhao Q
Mol Biol Rep; 2013 Nov; 40(11):6287-93. PubMed ID: 24062073
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.
Giuliano M; Pellerito O; Portanova P; Calvaruso G; Santulli A; De Blasio A; Vento R; Tesoriere G
Biochimie; 2009 Apr; 91(4):457-65. PubMed ID: 19059457
[TBL] [Abstract][Full Text] [Related]
16. [The effect of the activation of cannabinoid receptor on the proliferation and apoptosis of hepatoma HepG2 cells].
Wang Y; Zhou YT; Zhao Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Apr; 26(4):344-7. PubMed ID: 20368112
[TBL] [Abstract][Full Text] [Related]
17. R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor.
Sánchez AJ; González-Pérez P; Galve-Roperh I; García-Merino A
Biochem Pharmacol; 2006 Dec; 72(12):1697-706. PubMed ID: 17007821
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
[TBL] [Abstract][Full Text] [Related]
19. The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.
Morell C; Bort A; Vara D; Ramos-Torres A; Rodríguez-Henche N; Díaz-Laviada I
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):248-57. PubMed ID: 27324222
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]